408 related articles for article (PubMed ID: 26310078)
1. Unique Biological Degradation Behavior of Stöber Mesoporous Silica Nanoparticles from Their Interiors to Their Exteriors.
Chen G; Teng Z; Su X; Liu Y; Lu G
J Biomed Nanotechnol; 2015 Apr; 11(4):722-9. PubMed ID: 26310078
[TBL] [Abstract][Full Text] [Related]
2. Novel scheme for rapid synthesis of hollow mesoporous silica nanoparticles (HMSNs) and their application as an efficient delivery carrier for oral bioavailability improvement of poorly water-soluble BCS type II drugs.
Li T; Geng T; Md A; Banerjee P; Wang B
Colloids Surf B Biointerfaces; 2019 Apr; 176():185-193. PubMed ID: 30616109
[TBL] [Abstract][Full Text] [Related]
3. In vitro degradation behavior of silica nanoparticles under physiological conditions.
Hao N; Liu H; Li L; Chen D; Li L; Tang F
J Nanosci Nanotechnol; 2012 Aug; 12(8):6346-54. PubMed ID: 22962747
[TBL] [Abstract][Full Text] [Related]
4. A Biodegradation Study of SBA-15 Microparticles in Simulated Body Fluid and in Vivo.
Choi Y; Lee JE; Lee JH; Jeong JH; Kim J
Langmuir; 2015 Jun; 31(23):6457-62. PubMed ID: 26013363
[TBL] [Abstract][Full Text] [Related]
5. Synthesis of mesoporous silica nanoparticles.
Wu SH; Mou CY; Lin HP
Chem Soc Rev; 2013 May; 42(9):3862-75. PubMed ID: 23403864
[TBL] [Abstract][Full Text] [Related]
6. Mesoporous silica nanoparticles for intracellular controlled drug delivery.
Vivero-Escoto JL; Slowing II; Trewyn BG; Lin VS
Small; 2010 Sep; 6(18):1952-67. PubMed ID: 20690133
[TBL] [Abstract][Full Text] [Related]
7. Mesoporous silica nanoparticles for therapeutic/diagnostic applications.
Jafari S; Derakhshankhah H; Alaei L; Fattahi A; Varnamkhasti BS; Saboury AA
Biomed Pharmacother; 2019 Jan; 109():1100-1111. PubMed ID: 30551360
[TBL] [Abstract][Full Text] [Related]
8. Mesoporous silica nanoparticles with organo-bridged silsesquioxane framework as innovative platforms for bioimaging and therapeutic agent delivery.
Du X; Li X; Xiong L; Zhang X; Kleitz F; Qiao SZ
Biomaterials; 2016 Jun; 91():90-127. PubMed ID: 27017579
[TBL] [Abstract][Full Text] [Related]
9. Intracellular degradation of multilabeled poly(ethylene imine)-mesoporous silica-silica nanoparticles: implications for drug release.
Bergman L; Kankaanpää P; Tiitta S; Duchanoy A; Li L; Heino J; Lindén M
Mol Pharm; 2013 May; 10(5):1795-803. PubMed ID: 23510188
[TBL] [Abstract][Full Text] [Related]
10. Facile, one-pot synthesis, and antibacterial activity of mesoporous silica nanoparticles decorated with well-dispersed silver nanoparticles.
Tian Y; Qi J; Zhang W; Cai Q; Jiang X
ACS Appl Mater Interfaces; 2014 Aug; 6(15):12038-45. PubMed ID: 25050635
[TBL] [Abstract][Full Text] [Related]
11. Preparation and Controllability of Mesoporous Silica Nanoparticles.
Yamamoto E; Kuroda K
Enzymes; 2018; 44():1-10. PubMed ID: 30360809
[TBL] [Abstract][Full Text] [Related]
12. Polydopamine-based surface modification of mesoporous silica nanoparticles as pH-sensitive drug delivery vehicles for cancer therapy.
Chang D; Gao Y; Wang L; Liu G; Chen Y; Wang T; Tao W; Mei L; Huang L; Zeng X
J Colloid Interface Sci; 2016 Feb; 463():279-87. PubMed ID: 26550786
[TBL] [Abstract][Full Text] [Related]
13. Following in Situ the Degradation of Mesoporous Silica in Biorelevant Conditions: At Last, a Good Comprehension of the Structure Influence.
Bindini E; Chehadi Z; Faustini M; Albouy PA; Grosso D; Cattoni A; Chanéac C; Azzaroni O; Sanchez C; Boissière C
ACS Appl Mater Interfaces; 2020 Mar; 12(12):13598-13612. PubMed ID: 32077678
[TBL] [Abstract][Full Text] [Related]
14. Enhanced biosafety of silica coated gadolinium based nanoparticles.
Laranjeira M; Shirosaki Y; Yoshimatsu Yasutomi S; Miyazaki T; Monteiro FJ
J Mater Sci Mater Med; 2017 Mar; 28(3):46. PubMed ID: 28161832
[TBL] [Abstract][Full Text] [Related]
15. Coordination-Accelerated "Iron Extraction" Enables Fast Biodegradation of Mesoporous Silica-Based Hollow Nanoparticles.
Wang L; Huo M; Chen Y; Shi J
Adv Healthc Mater; 2017 Nov; 6(22):. PubMed ID: 28941142
[TBL] [Abstract][Full Text] [Related]
16. Mesoporous silica nanoparticles: synthesis, biocompatibility and drug delivery.
Tang F; Li L; Chen D
Adv Mater; 2012 Mar; 24(12):1504-34. PubMed ID: 22378538
[TBL] [Abstract][Full Text] [Related]
17. DNA-templated in situ growth of silver nanoparticles on mesoporous silica nanospheres for smart intracellular GSH-controlled release.
Liu C; Qing Z; Zheng J; Deng L; Ma C; Li J; Li Y; Yang S; Yang J; Wang J; Tan W; Yang R
Chem Commun (Camb); 2015 Apr; 51(30):6544-7. PubMed ID: 25765340
[TBL] [Abstract][Full Text] [Related]
18. One-step synthesis of degradable T(1)-FeOOH functionalized hollow mesoporous silica nanocomposites from mesoporous silica spheres.
Peng YK; Tseng YJ; Liu CL; Chou SW; Chen YW; Tsang SC; Chou PT
Nanoscale; 2015 Feb; 7(6):2676-87. PubMed ID: 25581508
[TBL] [Abstract][Full Text] [Related]
19. Peptide-laden mesoporous silica nanoparticles with promoted bioactivity and osteo-differentiation ability for bone tissue engineering.
Luo Z; Deng Y; Zhang R; Wang M; Bai Y; Zhao Q; Lyu Y; Wei J; Wei S
Colloids Surf B Biointerfaces; 2015 Jul; 131():73-82. PubMed ID: 25969416
[TBL] [Abstract][Full Text] [Related]
20. Hydrolytic surface erosion of mesoporous silica nanoparticles for efficient intracellular delivery of cytochrome c.
Choi E; Lim DK; Kim S
J Colloid Interface Sci; 2020 Feb; 560():416-425. PubMed ID: 31679782
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
